TW200637826A - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
TW200637826A
TW200637826A TW095101427A TW95101427A TW200637826A TW 200637826 A TW200637826 A TW 200637826A TW 095101427 A TW095101427 A TW 095101427A TW 95101427 A TW95101427 A TW 95101427A TW 200637826 A TW200637826 A TW 200637826A
Authority
TW
Taiwan
Prior art keywords
compounds
chemical compounds
preparing
processes
formula
Prior art date
Application number
TW095101427A
Other languages
English (en)
Chinese (zh)
Inventor
Andrew Baxter
Sarah King
Austen Pimm
Chris Luckhurst
Mark Furber
James Reuberson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200637826A publication Critical patent/TW200637826A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095101427A 2005-01-13 2006-01-13 Chemical compounds TW200637826A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0500105 2005-01-13

Publications (1)

Publication Number Publication Date
TW200637826A true TW200637826A (en) 2006-11-01

Family

ID=36677916

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095101427A TW200637826A (en) 2005-01-13 2006-01-13 Chemical compounds

Country Status (3)

Country Link
AR (1) AR052457A1 (fr)
TW (1) TW200637826A (fr)
WO (1) WO2006075955A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200838515A (en) * 2007-02-09 2008-10-01 Takeda Pharmaceutical Fused ring compound
US12030879B2 (en) 2018-03-02 2024-07-09 Inflazome Limited Sulfonyl acetamides as NLRP3 inhibitors
WO2019166632A1 (fr) 2018-03-02 2019-09-06 Inflazome Limited Nouveaux composés
EP3759078A1 (fr) 2018-03-02 2021-01-06 Inflazome Limited Nouveaux composés
WO2019166627A1 (fr) 2018-03-02 2019-09-06 Inflazome Limited Nouveaux composés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11511133A (ja) * 1995-08-02 1999-09-28 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗薬
EP0885890A1 (fr) * 1996-02-26 1998-12-23 Sumitomo Pharmaceuticals Company, Limited Derives de sulfonylureidopyrazole
CA2315614C (fr) * 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles

Also Published As

Publication number Publication date
WO2006075955A1 (fr) 2006-07-20
AR052457A1 (es) 2007-03-21

Similar Documents

Publication Publication Date Title
TW200801003A (en) Novel compounds
TW200738659A (en) Novel compounds
TW200800999A (en) Novel compounds
TW200833670A (en) Novel compounds 569
ATE433447T1 (de) Pyrimiidinverbindungen
TW200716529A (en) New compounds II
TW200745084A (en) Novel compounds
SE0301700D0 (sv) Novel compounds
MX2009010047A (es) Compuestos quimicos.
TW200635921A (en) Organic compounds
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
TW200640908A (en) Chemical compounds
TW200616995A (en) Novel compounds
MX2009010045A (es) Compuestos quimicos.
TW200617009A (en) Organic compounds
TW200615266A (en) Organic compounds
TW200745067A (en) Novel compounds
TW200639156A (en) New compounds
TW200738658A (en) Novel compounds
TW200745122A (en) New compounds I
TW200740781A (en) Novel compounds
GB0508314D0 (en) Organic compounds
UA96277C2 (en) Benzimidazole derivatives
TW200605888A (en) Novel compounds
TW200635916A (en) Compounds